Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRAETORIAN-COVID: Valsartan for Prevention of ARDS in COVID-19
NCT04335786Phase 4Terminated
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of valsartan in coronavirus disease 2019 (COVID-19), sponsored by Radboud University Medical Center. Started Apr 2020; status: terminated.
02
Drugs
valsartan
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04335786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04335786.